The Cancer Therapy &Research Center (CTRC) is led by Director, Ian M. Thompson, Jr., M.D. Dr. Thompson is assisted in this role by a Senior Leadership team, comprised of a Deputy Director and five Associate Directors, each of whom has expertise in their area of responsibility. They are: Tim H-M. Huang, Ph.D., Deputy Director;Karen Block, Ph.D., Associate Director for Shared Resources;Susan Padalecki, Ph.D., Associate Director for Research Administration;Amelie Ramirez, Dr. P.H., Associate Director for Cancer Prevention and Health Disparities;LuZhe Sun, Ph.D., Associate Director for Translational Research; and Steven Weitman, M.D., Ph.D., Associate Director for Clinical Research. The CTRC Senior Leadership team meets weekly with the Leaders of the CTRC Scientific Programs as an Executive Committee. One on one meetings with the Director and each other occur frequently as needed. Members of the Senior Leadership team provide counsel and recommendations to the Director based on these interactions and their interactions with the CTRC membership. Final authority for decisions on behalf of the CTRC resides with the Director. The Senior Leadership works directly with the Program Leaders, Shared Resource Directors, and other CTRC committees to build consensus on CTRC-wide priorities, strategies, and allocation of resources. The Senior Leaders ensure consistency in the mission, vision, and goals of the CTRC and develop synergistic interactions among the basic, translational, and clinical elements of the Center. They provide feedback on the growth and the needs of the CTRC in their area of responsibility. They also plan and implement proactive, integrative approaches for development of the research base, resources, and a formal strategic plan.

Public Health Relevance

Support is requested for the Senior Leadership of the Cancer Therapy &Research Center (CTRC). This leadership is critical to ensuring the overall success of the CTRC in fulfilling its mission and meeting its goals and in the strategic planning and evaluation of all CTRC efforts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-20
Application #
8758433
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M3))
Project Start
1997-08-01
Project End
2019-07-31
Budget Start
2014-09-16
Budget End
2015-07-31
Support Year
20
Fiscal Year
2014
Total Cost
$187,026
Indirect Cost
$39,732
Name
University of Texas Health Science Center
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Zanotto-Filho, Alfeu; Dashnamoorthy, Ravi; Loranc, Eva et al. (2016) Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human. PLoS One 11:e0153970
Newcomb, Lisa F; Thompson Jr, Ian M; Boyer, Hilary D et al. (2016) Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol 195:313-20
Ortiz, Carmen; Morales, Luisa; Sastre, Miguel et al. (2016) Cytotoxicity and Genotoxicity Assessment of Sandalwood Essential Oil in Human Breast Cell Lines MCF-7 and MCF-10A. Evid Based Complement Alternat Med 2016:3696232
Price, Douglas K; Chau, Cindy H; Till, Cathee et al. (2016) Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer 122:2332-40
Zanotto-Filho, Alfeu; Masamsetti, V Pragathi; Loranc, Eva et al. (2016) Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis. Mol Cancer Ther 15:3000-3014
Sareddy, Gangadhara R; Li, Xiaonan; Liu, Jinyou et al. (2016) Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma. Sci Rep 6:24185
Sweeney, Shannon R; Kavanaugh, Arthur; Lodi, Alessia et al. (2016) Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. RMD Open 2:e000289
Schenk, Jeannette M; Till, Cathee; Hsing, Ann W et al. (2016) Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes Control 27:175-82
Toledo, Rodrigo A; Qin, Yuejuan; Cheng, Zi-Ming et al. (2016) Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas. Clin Cancer Res 22:2301-10
Wu, Anqi; Dong, Qiaoxiang; Gao, Hui et al. (2016) Characterization of mammary epithelial stem/progenitor cells and their changes with aging in common marmosets. Sci Rep 6:32190

Showing the most recent 10 out of 853 publications